|
Sign In to gain access to subscriptions and/or personal tools.
|
Definitive vs. Exploratory Periodontal Trials: A Survey of Published Studies
P.P. Hujoel
Department of Dental Public Health Sciences, School of Dentistry, Box 357475, University of Washington, Seattle, Washington 98195
Definitive and exploratory randomized controlled trials (RCTs) have different goals as well as different design and analysis characteristics. The goal of definitive studies is to provide unequivocal evidence of a treatment's tangible benefit to the patient; a pre-trial-specified hypothesis is tested by use of a pre-trial-specified method.The goal of exploratory studies is to elucidate biological treatment mechanisms, to identify promising treatments, and to generate hypotheses for definitive studies; multiple hypotheses are evaluated to extract as much information from the data as possible. The purposes of this study were: (1) to survey selected design and analysis characteristics of randomized controlled periodontal trials published between 1988 and 1992 (n = 86), and (2) to classify trials as exploratory or definitive studies. The periodontal RCTs surveyed were typical of exploratory studies whose primary goal was to elucidate biological treatment mechanisms. Trial reports indicated the testing of multiple hypotheses ( 6 hypothesis tests in 70 of the 86 trials) on a variety of biological markers (86 out of 86 trials). The sample size ( 30 subjects in 67 out of 86 trials), duration (< 6 months in 65 out of 86 trials), and design and analysis characteristics (e.g., an absence of masking in 57 out of 86 trials) were also typical of exploratory studies which strive to obtain quick answers (short duration) at a low cost (small sample size; accept bias for increased efficiency and a lower cost). No definitive trials were identified. Promising, biologically active, treatments identified in exploratory trials should be evaluated in definitive studies where the primary goal is the procurement of unequivocal evidence of a treatment's tangible benefit to the patient. The costs and benefits of conducting definitive periodontal RCTs to provide such evidence should be investigated.
Key Words: randomized controlled trials Phase III exploratory trials
REFERENCES
- Bardhan KD (1987). Unfavourable results and drug company trials (letter). Lancet 1:1492.[Medline]
[Order article via Infotrieve]
- Blumenthal D., Gluck M., Louis KS, Stoto MA, Wise D. ( 1986a). University-industry research relationships in biotechnology: implications for the university. Science 232:1361-1366.[Abstract/Free Full Text]
- Blumenthal D., Gluck M., Louis KS, Wise D. ( 1986b). Industrial support of university research in biotechnology. Science 231:242-246.[Abstract/Free Full Text]
- Boissel JP, Collet JP, Moleur P., Haugh M. (1992). Surrogate endpoints: a basis for a rational approach. Eur J Clin Pharmacol 43:235-244.[CrossRef][Medline]
[Order article via Infotrieve]
- Brody BA (1995). Ethical issues in drug testing, approval, and pricing. The clot-dissolving drugs. Oxford: Oxford University Press.
- Ciancio SG (1994). Editorial. Periodontal Insights. A Newsletter for the Dental Team. 1:1.
- Colditz G., Miller J., Mosteller F. (1989). How study design affects outcomes in comparisons of therapy. I: Medical. Statistics in Medicine 8:441-454.[Medline]
[Order article via Infotrieve]
- Council on Scientific Affairs and Council on Ethical and Judicial Affairs (1990). Conflicts of interest in medical center/industry research relationships. J Am Med Assoc
- 263:2790-2793.
- Ellenberg SS (1993). Surrogate endpoints [editorial]. Br J Cancer 68:457-459.[Medline]
[Order article via Infotrieve]
- Ellenberg S., Hamilton JM (1989). Surrogate endpoints in clinical trials: cancer. Stat Med 8:405-413.[Medline]
[Order article via Infotrieve]
- Fleming TR (1992). Evaluating therapeutic interventions: some issues and experiences. Statistical Sciences 7:428-456.
- Fleming TR (1994). Surrogate markers in AIDS and cancer trials. Stat Med 13:1423-1435.[Medline]
[Order article via Infotrieve]
- Fleming TR (1988). Design considerations for clinical trials. In: Cancer chemotherapy: Challenges for the future. Vol. 3. Kimura K, editor. Tokyo: Excerpta Medica, pp. 299-307.
- Fleming TR, DeMets DL (1993). Monitoring of clinical trials: Issues and recommendations. Controlled Clinical Trials 14:23-38.
- Gehan EA (1990). How to find a cure for cancer. J Irreproduc Results 35:2-4.
- Gilbert JP, McPeek B., Mosteller F. (1977). Progress in surgery and anesthesia: Benefits and risks of innovative therapy. In: Cost, risks, and benefits of surgery. Bunker JP, Barnes BA, Mosteller F, editors. New York: Oxford University Press, pp. 124-169.
- Hirschfeld L., Wasserman B. (1978). A long-term survey of tooth loss in 600 treated periodontal patients. J Periodontol 49:225-237.[Medline]
[Order article via Infotrieve]
- Hujoel PP, DeRouen TA (1992). Validity issues in split-mouth trials. J Clin Periodontol 19:625-627.[CrossRef][Medline]
[Order article via Infotrieve]
- Hujoel PP, DeRouen TA (1995). A survey of endpoint characteristics in periodontal clinical trials published 1988-1992, and implications for future studies. J Clin Periodontol 22:397-407.[CrossRef][Medline]
[Order article via Infotrieve]
- Hujoel PP, Baab DA, DeRouen TA (1992). Power of statistical tests in periodontal trials. J Clin Periodontol 19:779-784.[Medline]
[Order article via Infotrieve]
- Institute for Scientific Information (1992 ). Science citation index-Journal citation reports. Philadelphia, PA.
- Lagakos S. (1992). Comment. Statistical Science 7:449-450. Lauritsen K., Havelund T., Laursen LS, Rask-Madsen J. (1987). Withholding unfavourable results in drug company sponsored clinical trials [letter]. Lancet 1:1091.[Medline]
[Order article via Infotrieve]
- Marriott FHC (1988). A dictionary of statistical terms. Singapore: Longman Singapore Publishers Ltd.
- Mills JL (1993). Data torturing. New Engl J Med 329:1196-1199. Nowak R. (1994). Problems in clinical trials go far beyond misconduct [news]. Science 264:1538-1541.[Free Full Text]
- Petitti DB (1994). Meta-analysis decision analysis and cost-effectiveness analysis. Methods for quantitative synthesis in medicine. New York: Oxford University Press.
- Pocock SJ (1983). Clinical trials: a practical approach. New York: Wiley.
- Prentice RL (1989). Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 8:431-440.[Medline]
[Order article via Infotrieve]
- Prentice RL (1991). Aspects of the science of cancer prevention trials: lessons from the conduct and planning of clinical trials of a low-fat diet intervention among women. Prev Med 20:147-157.[Medline]
[Order article via Infotrieve]
- Ramfjord SP (1987). Surgical periodontal pocket elimination: still a justifiable objective? J Am Dent Assoc 114:37-40.[Medline]
[Order article via Infotrieve]
- Roberts AH, Kewman DG, Mercier L., Hovell MF (1993). The power of nonspecific effects in healing: Implications for psychosocial and biological treatments. Clin Psychol Rev 13:375-391.[CrossRef]
- Rothman KJ (1993a). Conflict of interest. The new McCarthyism in science. J Am Med Assoc 269:2782-2784.[Abstract/Free Full Text]
- Rothman KJ (1993b). Journal policies on conflict of interest [letter]. Science 261:1661.[Free Full Text]
- Self GS, Mauritsen RH, Ohara J. (1992). Power calculations for likelihood ratio tests in generalized linear models. Biometrics 48:31-39.
- Signorini DF (1991). Sample size for Poisson regression. Biometrika 78:446-450.[Abstract/Free Full Text]
- Stephens MDB (1993). Detection of new adverse drug reactions. New York: Van Nostrand Reinhold.
- Steward WP, Vantongelen K., Verweij J., Thomas D., Van-Oosterom AT (1993). Chemotherapy administration and data collection in an EORTC collaborative group-can we trust the results? Eur J Cancer 7:943-947.
- The advanced colorectal cancer meta-analysis project (1992). Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project [see comments]. J Clin Oncol 10:896-903.[Abstract]
- Weiss RB, Vogelzang NJ, Peterson BA, Panasci LC, Carpenter JT, Gavigan M., et al. (1993). A successful system of scientific data audits for clinical trials. A report from the Cancer and Leukemia Group B [see comments]. J Am Med Assoc 270:459-464.[Abstract/Free Full Text]
- Yusuf S., Collins R., Peto R. ( 1984). Why do we need some large, simple randomized trials? Stat Med 3:409-420.[Medline]
[Order article via Infotrieve]
- Yusuf S., Wittes J., Probstfield J., Tyroler HA (1991). Analyses and interpretation of treatment effects in subgroups of patients in randomized controlled trials. J Am Med Assoc 266:93-98.[Abstract/Free Full Text]
Journal of Dental Research, Vol. 74, No. 8,
1453-1458 (1995)
DOI: 10.1177/00220345950740080401

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P.P. Hujoel, B.G. Leroux, T.A. DeRouen, L.V. Powell, and H.A. Kiyak
Evaluating the Validity of Probing Attachment Loss as a Surrogate for Tooth Mortality in a Clinical Trial on the Elderly
Journal of Dental Research,
April 1, 1997;
76(4):
858 - 866.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P.P. Hujoel, L.V. Powell, and H.A. Kiyak
The Effects of Simple Interventions on Tooth Mortality: Findings in One Trial and Implications for Future Studies
Journal of Dental Research,
April 1, 1997;
76(4):
867 - 874.
[Abstract]
[PDF]
|
 |
|
|
|